Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes

BACKGROUND: Anti-factor Xa assays and activated partial thromboplastin time (aPTT) are mainly employed to monitor patients treated with heparins. According to the Clinical and Laboratory Standards Institute and the French Working Group on Haemostasis and Thrombosis, anti-factor Xa activity and aPTT...

Descripción completa

Detalles Bibliográficos
Autores principales: Gremillet, Marion, Talon, Laurie, Lebreton, Aurélien, Sinegre, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942401/
https://www.ncbi.nlm.nih.gov/pubmed/36803983
http://dx.doi.org/10.1186/s12959-023-00465-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942401/
https://www.ncbi.nlm.nih.gov/pubmed/36803983
http://dx.doi.org/10.1186/s12959-023-00465-8

Ejemplares similares